Experimental Obesity Drug Avoids Brain Effects That Troubled Predecessors

Experimental Obesity Drug Avoids Brain Effects That Troubled Predecessors
Findings raise the prospect of reviving the idea of CB1 receptor blockade for fighting obesity and related diseasesA second-generation experimental anti-obesity and diabetes drug has shown promise in reducing body weight in rodents just as effectively as the predecessor rimonabant while avoiding the risk of psychiatric side effects that led to the withdrawal of rimonabant from the market and …
Read more on redOrbit

Fellowships for outstanding research in drug use and HIV are presented by the International AIDS Society and the …
( International AIDS Society ) The International AIDS Society and the National Institute on Drug Abuse today announced the recipients of their second annual joint research fellowships. Recipients of the prestigious awards will receive ,000 each to advance the scientific understanding of the linkage between illicit drug use and HIV, while fostering multinational research.
Read more on EurekAlert!

Father dies day after receiving breakthrough cancer drug he had battled for five months to get
The family of Stuart Cunningham, 51, were left heartbroken after he succumbed to the disease without getting the chance to try the drug, known as Afinitor.
Read more on Daily Mail